UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy

Clinical trial NCT06047886 · RECRUITING

Trial details

NCT number: NCT06047886
Sponsor: University of Alabama at Birmingham
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

AML ALL Lymphoid Malignancies Myelodysplastic Syndromes CML Primary Myelofibrosis

Start date: 2025-04-22
Primary completion: 2029-10-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.